RIGL
NASDAQ · Biotechnology
Rigel Pharmaceuticals Inc
$25.96
-0.14 (-0.54%)
Open$26.02
Previous Close$26.10
Day High$26.47
Day Low$25.52
52W High$52.24
52W Low$15.50
Volume—
Avg Volume271.0K
Market Cap660.53M
P/E Ratio5.83
EPS$6.17
SectorBiotechnology
Analyst Ratings
Buy
12 analysts
Price Target
+108.4% upside
Current
$25.96
$25.96
Target
$54.10
$54.10
$39.68
$54.10 avg
$74.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 184.14M | 173.21M | 385.25M |
| Net Income | 17.96M | 15.20M | -63,461,041 |
| Profit Margin | 9.8% | 9.3% | -16.5% |
| EBITDA | 27.14M | 24.25M | -108,813,206 |
| Free Cash Flow | — | — | -71,858,369 |
| Rev Growth | +6.3% | +6.3% | +12.7% |
| Debt/Equity | 18.15 | 18.15 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |